Chemoinformaics analysis of 9-Deoxygoniopypyrone
| Molecular Weight | 234.251 | nRot | 1 |
| Heavy Atom Molecular Weight | 220.139 | nRig | 7 |
| Exact Molecular Weight | 234.089 | nRing | 3 |
| Solubility: LogS | -1.917 | nHRing | 2 |
| Solubility: LogP | 1.637 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 34.2531 |
| nHD | 1 | BPOL | 18.3849 |
| QED | 0.602 |
| Synth | 1.341 |
| Natural Product Likeliness | -0.445 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.38 |
| MDCK | 0.0000272 |
| BBB | 0.733 |
| PPB | 0.686086 |
| VDSS | 0.748 |
| FU | 0.274169 |
| CYP1A2-inh | 0.971 |
| CYP1A2-sub | 0.944 |
| CYP2c19-inh | 0.842 |
| CYP2c19-sub | 0.711 |
| CYP2c9-inh | 0.207 |
| CYP2c9-sub | 0.794 |
| CYP2d6-inh | 0.04 |
| CYP2d6-sub | 0.832 |
| CYP3a4-inh | 0.042 |
| CYP3a4-sub | 0.349 |
| CL | 7.715 |
| T12 | 0.83 |
| hERG | 0.089 |
| Ames | 0.138 |
| ROA | 0.098 |
| SkinSen | 0.217 |
| Carcinogencity | 0.771 |
| EI | 0.991 |
| Respiratory | 0.149 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.647664 |